These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30128692)

  • 21. A transgenic minipig model of Huntington's disease shows early signs of behavioral and molecular pathologies.
    Askeland G; Rodinova M; Štufková H; Dosoudilova Z; Baxa M; Smatlikova P; Bohuslavova B; Klempir J; Nguyen TD; Kuśnierczyk A; Bjørås M; Klungland A; Hansikova H; Ellederova Z; Eide L
    Dis Model Mech; 2018 Oct; 11(10):. PubMed ID: 30254085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large Animal Models of Huntington's Disease: What We Have Learned and Where We Need to Go Next.
    Howland D; Ellederova Z; Aronin N; Fernau D; Gallagher J; Taylor A; Hennebold J; Weiss AR; Gray-Edwards H; McBride J
    J Huntingtons Dis; 2020; 9(3):201-216. PubMed ID: 32925082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Testing of HTT Modifiers for Huntington's Disease: Considerations for Clinical Guidelines.
    Goldman JS; Uhlmann WR; Naini AB; Klitzman RL; Marder KS
    Mov Disord; 2023 Dec; 38(12):2151-2154. PubMed ID: 37975739
    [No Abstract]   [Full Text] [Related]  

  • 24. In vivo proof-of-concept of removal of the huntingtin caspase cleavage motif-encoding exon 12 approach in the YAC128 mouse model of Huntington's disease.
    Casaca-Carreira J; Toonen LJA; Evers MM; Jahanshahi A; van-Roon-Mom WMC; Temel Y
    Biomed Pharmacother; 2016 Dec; 84():93-96. PubMed ID: 27639545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Back-to-BACs in Huntington's disease modeling.
    Lee H; Heiman M
    Neuron; 2022 Apr; 110(7):1087-1089. PubMed ID: 35390285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mGluR5 antagonism increases autophagy and prevents disease progression in the
    Abd-Elrahman KS; Hamilton A; Hutchinson SR; Liu F; Russell RC; Ferguson SSG
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington's Disease Knock-In Mice.
    Neto JL; Lee JM; Afridi A; Gillis T; Guide JR; Dempsey S; Lager B; Alonso I; Wheeler VC; Pinto RM
    Genetics; 2017 Feb; 205(2):503-516. PubMed ID: 27913616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutated Huntingtin Causes Testicular Pathology in Transgenic Minipig Boars.
    Macakova M; Bohuslavova B; Vochozkova P; Pavlok A; Sedlackova M; Vidinska D; Vochyanova K; Liskova I; Valekova I; Baxa M; Ellederova Z; Klima J; Juhas S; Juhasova J; Klouckova J; Haluzik M; Klempir J; Hansikova H; Spacilova J; Collins R; Blumenthal I; Talkowski M; Gusella JF; Howland DS; DiFiglia M; Motlik J
    Neurodegener Dis; 2016; 16(3-4):245-59. PubMed ID: 26959244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress in developing transgenic monkey model for Huntington's disease.
    Snyder BR; Chan AWS
    J Neural Transm (Vienna); 2018 Mar; 125(3):401-417. PubMed ID: 29127484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Huntington's disease on the threshold of a new era in treatment?
    Sandy S; Richard A
    Neurodegener Dis Manag; 2019 Oct; 9(5):255-258. PubMed ID: 31580228
    [No Abstract]   [Full Text] [Related]  

  • 31. Huntington's Disease and Diabetes: Chronological Sequence of its Association.
    Montojo MT; Aganzo M; González N
    J Huntingtons Dis; 2017; 6(3):179-188. PubMed ID: 28968242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation and Characterization of Knock-in Mouse Models Expressing Versions of Huntingtin with Either an N17 or a Combined PolyQ and Proline-Rich Region Deletion.
    André EA; Braatz EM; Liu JP; Zeitlin SO
    J Huntingtons Dis; 2017; 6(1):47-62. PubMed ID: 28211815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Huntington's disease CAG Repeat Length Stability in Human Motor Cortex and Cingulate Gyrus.
    Geraerts FC; Snell RG; Faull RL; Williams L; Jacobsen JC; Reid SJ
    J Huntingtons Dis; 2016 Oct; 5(3):297-301. PubMed ID: 27716680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-Related Oxidative Changes in Primary Porcine Fibroblasts Expressing Mutated Huntingtin.
    Smatlikova P; Askeland G; Vaskovicova M; Klima J; Motlik J; Eide L; Ellederová Z
    Neurodegener Dis; 2019; 19(1):22-34. PubMed ID: 31167196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translating Antisense Technology into a Treatment for Huntington's Disease.
    Lane RM; Smith A; Baumann T; Gleichmann M; Norris D; Bennett CF; Kordasiewicz H
    Methods Mol Biol; 2018; 1780():497-523. PubMed ID: 29856033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using Drosophila models of Huntington's disease as a translatable tool.
    Lewis EA; Smith GA
    J Neurosci Methods; 2016 May; 265():89-98. PubMed ID: 26241927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Huntington's Disease: Relationship Between Phenotype and Genotype.
    Sun YM; Zhang YB; Wu ZY
    Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular Analysis of Silencing the Huntington's Disease Gene Using AAV9 Mediated Delivery of Artificial Micro RNA into the Striatum of Q140/Q140 Mice.
    Keeler AM; Sapp E; Chase K; Sottosanti E; Danielson E; Pfister E; Stoica L; DiFiglia M; Aronin N; Sena-Esteves M
    J Huntingtons Dis; 2016 Oct; 5(3):239-248. PubMed ID: 27689620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Huntington's disease: 4 big questions.
    Nowogrodzki A
    Nature; 2018 May; 557(7707):S48. PubMed ID: 29844555
    [No Abstract]   [Full Text] [Related]  

  • 40. Murine Models of Huntington's Disease for Evaluating Therapeutics.
    Kosior N; Leavitt BR
    Methods Mol Biol; 2018; 1780():179-207. PubMed ID: 29856020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.